Innovative Therapeutics for Advanced Lung Disease
- Start Date:
- Thursday, 2 March, 2017
- End Date:
- Thursday, 2 March, 2017 4:20pm
- Internal Medicine, Pulmonary Medicine, Critical Care
Worldwide COPD and lower respiratory tract infections are tied for the third leading causes of death behind only cardiovascular disease and stroke. However, if one combines the mortality figures for COPD, lower respiratory tract infections, and cancers of lung, bronchus, trachea, data suggests diseases of the chest are now the number one cause of death worldwide. Recognizing its importance, the Divisions of Thoracic Surgery and Pulmonary Medicine are hosting a symposium on treating advanced lung disease.Topics will include COPD, interstitial lung diseases, mycobacterial disease, pulmonary vascular disease, acute respiratory failure, lung cancer and diaphragmatic dysfunction.
The symposium will explore cutting edge approaches to some of these issues including medical advances, and more interventional approaches such as extracorporeal membrane oxygenation, lung volume reduction surgery, endobronchial lung volume reduction, lung transplantation, pulmonary thromboendarterectomy, diaphragm plication and pacing.
173 Fort Washington Avenue,
Conference organized by NewYork-Presbyterian/Columbia University Medical Center
After completing Essentials in Pain Management: Update 2017, you will be able to:Understand the neurobiology of chronic pain and pain perceptionIdentify comprehensive treatment principles in complex chronic pain conditionsUnderstand the approach to controlled substance prescription and diversion resistant modalitiesUnderstand the pharmacology of medical marijuana, the evidence for its usage and the legalities of prescribingDelineate a multidisciplinary approach to chronic pain management in patients with a special focus on the latest therapies including dorsal root ganglion stimulationUnderstand the latest research foci in pain medicine including the utility of cutting edge measures such as digiceuticals, virtual reality, pharmacogenetics and stem cell therapies
- 173 Fort Washington Avenue, New York, NY, 10032